Aspects of emergency vaccination against foot-and-mouth disease

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 25, Issue 5-6, 2002, Pages 345-364

  Barnett, P ^a   Garland, A J M ^b   Kitching, R P ^c   Schermbrucker, C G ^d  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b Dawney Hill ^*  (United Kingdom)

^c CANADIAN FOOD INSPECTION AGENCY   (Canada)

^d Thundery Hill   (United Kingdom)

Author keywords

Emergency vaccination; Foot and mouth disease; Vaccination; Vaccine banks

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; VIRUS ANTIGEN;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE CONTROL; DISINFECTION; DRUG EFFICACY; DRUG FORMULATION; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG POTENCY; DRUG RESEARCH; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; EARLY DIAGNOSIS; ECONOMIC ASPECT; EMERGENCY TREATMENT; EPIDEMIC; FOOT AND MOUTH DISEASE; LIVESTOCK; MEDICAL INFORMATION; MEDICAL PERSONNEL; MEDICAL RESEARCH; NONHUMAN; SANITATION; SLAUGHTERHOUSE; SPECIES; TREATMENT PLANNING; VACCINATION; VIRUS STRAIN;

ANIMALS; CARRIER STATE; CATTLE; CATTLE DISEASES; DISEASE OUTBREAKS; DRUG STORAGE; FOOT-AND-MOUTH DISEASE; SHEEP; SHEEP DISEASES; SWINE; SWINE DISEASES; VACCINATION; VIRAL VACCINES;

ANIMALIA;

EID: 0036777894     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(02)00031-0     Document Type: Article

References (44)

1. Foot and mouth disease vaccine potency tests in cattle: The relationship of antigen dose, serum neutralising antibody response and protection from challenge
2. Evaluation of the antigenic variation within type A foot-and-mouth disease virus isolates from Asia
3. Implication of a quasispecies genome structure: Effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus
4. Development of foot-and-mouth disease virus strain characteristics-a review
5. Optimisation of the immune response to foot-and-mouth disease vaccine
6. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethyleneimine
7. In vitro method for safety testing of foot-and-mouth disease vaccines
8. Quantitative assessment of 146s particles of foot-and-mouth disease virus in preparations destined for vaccine
9. Prospects for improved vaccines
10. Emergency vaccination against foot-and-mouth disease: Rate of development of immunity and its implications for the carrier state
11. Foot-and-mouth disease vaccines from the European bank seem to be sufficiently stable for emergency vaccination
12. International vaccine bank for foot-and-mouth disease: Assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants
13. Vaccines for control of FMD worldwide: Production, selection and field performance. Diagnosis and Epidemiology of FMD in SE Asia
14. Foot-and-mouth disease: Vaccine design, past, present and future
15. Foot-and-mouth disease: A long known virus, but a current threat
16. Foot-and-mouth disease: The future of vaccine banks
17. The availability of foot and mouth disease vaccine for emergency vaccination in Europe
18. Long term stability and potency of antigen concentrates held by the international vaccine bank (IVB)
19. Foot-and-mouth disease vaccines based on antigens in the European vaccine bank are very potent
20. Further studies on the rate of development of protection in cattle given emergency vaccination against foot-and-mouth disease
21. Persistent infections with foot-and-mouth disease virus
22. Emergency vaccination of pigs against foot-and-mouth disease: Protection against disease and reduction in contact transmission
23. Emergency vaccination of sheep against foot-and-mouth disease: Protection against disease and reduction in contact transmission
24. Effect of emergency vaccines on local virus replication and virus persistence in sheep using two different adjuvant formulations
25. The suitability of foot-and-mouth disease antigens held by the International Vaccine Bank within a global context
26. Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge
27. Descriptive epidemiology of the foot-and-mouth disease epidemic in Great Britain: The first five months
28. Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccine
29. The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccine and the serum neutralising antibody response in cattle
30. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant non-structural proteins in ELISA
31. Repeated administration of maximum payload emergency vaccines made from inactivated purified antigen concentrates do not induce significant titres of antibodies against non-structural proteins of foot-and-mouth disease virus
32. Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculo virus-expressed specific proteins
33. An integrated model to predict the atmospheric spread of foot-and-mouth disease virus
34. Irreversible decision making in contagious animal disease control under uncertainty
35. Ring vaccination
36. An evaluation of alternate control strategies for foot-and-mouth disease in Australia; A regional approach
37. The economics of foot-and-mouth disease control
38. Vital elements for the control of foot-and-mouth disease by vaccination
39. A review of the foot-and-mouth disease situation on Turkey during the last decade, including a critical assessment of past national and international control programmes, and with recommendations for future control
40. The experience of Indonesia in the control and eradication of foot and mouth disease